ABSTRACT Antiviral and macrophage-priming activities in the supernatant medium of a subelone of a concanavalin A-stimulated mouse T-cell hybridoma were investigated. The two activities were associated with a molecular weight of approximately 50,000 and could not be separated by various approaches. Both activities were eliminated by a highly specific neutralizing antibody against mouse interferon-v, but not by antibody against interferon-a and -(P. The ratio of-priming to antiviral activity in the hybridoma culture supernate was indistinguishable from the ratio obtained with mouse interferon-yprepared by recombinant DNA technology. It was concluded from these data that the priming activity in hybridoma culture supernates was attributable to interferon-and that this mediator is one form of the lymphokine macrophage-activating factor. Interferon-y was greater than 800 times more efficient at priming mouse macrophages for tumor cell killing than was a mixture of interferon-a and -(3. This finding contributes to growing awareness that type II interferon may have greater immunoregulatory potential than type I interferons.
Macrophages can be activated to kill tumor cells in vitro by a nonspecific, extracellular mechanism that may be important in host defense against neoplastic cells in vivo. An important goal, therefore, is acquisition of better understanding of how the process of activation is regulated. Recently, it has been shown that under defined conditions the lymphokine macrophage-activating factor (MAF) does not render macrophages fully cytolytic (1) (2) (3) (4) (5) . Instead, it heightens their responsiveness to a second signal(s) that then triggers the expression of killing-i.e., MAF "primes" macrophages to respond to a second, triggering stimulus.
A cloned hybridoma (24/Gl) has been recognized that produces MAF, identified by its ability to prime mouse macrophages for tumor cell killing (6) . The hybridoma-derived MAF was shown by various biochemical and functional criteria to be indistinguishable from conventionally prepared MAF (6) . These supernates also contained antiviral activity attributed to interferon (IFN)-y.
We report here that the antiviral and macrophage-priming activities produced by cells of a subclone of 24/Gl are not dissociable by various approaches. These results, together with data obtained by using recombinant mouse IFN-y, support a conclusion that priming activity produced by this hybridoma is attributable to IFN-y. We also report here that IFN-y is much more potent as a macrophage priming agent than type I interferon is.
MATERIALS AND METHODS
Mice. Male C3H/HeN mice were obtained from Charles River Breeding Laboratories (Kingston, NY) and used at 6-9 weeks of age.
= Tissue Culture Media and Reagents. Modified Eagle's minimal essential medium (Auto-Pow ME medium) was prepared from a powdered mix and supplemented with sodium bicarbonate at 2 mg/ml, .2 mM glutamine (all from Flow Laboratories), injectable penicillin G potassium at 100 units/ml, injectable streptomycin sulfate at 100 pug/ml (both from Pfizer), and 15 mM Hepes (Sigma) (H-ME medium). Fetal bovine serum was obtained from Sterile Systems (Logan, UT). Dulbecco's modified minimum essential medium (D-ME medium) supplemented with 5% fetal bovine serum, antibiotics, and 50 ,AM 2-mercaptoethanol was used to culture the mouse T-cell hybridoma. All tissue culture media and the serum used in this study were negative for endotoxin, as determined by assay (7) with Limulus amebocyte lysate (Associates of Cape Cod, Woods Hole, MA); assay sensitivity was 0.1 ng of endotoxin per ml.
T-Cell Hybridoma Culture Supernates. Derivation of the Tcell hybridoma clone 24/G1 has been described (6, 8, 9) . Briefly, alloantigen-activated T-cell blasts were fused with T lymphoma BW5147. The hybrid cells were recloned in the laboratory of one of us (J.L.P.) by limiting dilution (0.5 cell per well; microscopic confirmation that each outgrowth came from a single cell). When used for lymphokine production, the cells were seeded at either 1 X 106 or 2 x 10 /ml in serum-free medium and stimulated for 24 hr with concanavalin A at 5 pug/ml (Pharmacia). Lymphokine-rich culture supernates were recovered by centrifugation (500 x g, 20 min, 4QC). After filtration (0.45-Am pore diameter), they were stored at 40C. Control culture supernates were similarly prepared, except that concanavalin A was added after the cells had been removed. Peritoneal Macrophages. Peritoneal exudate cells (PEG) were harvested by lavage from mice that had been injected intraperitoneally 3 days previously with 1.5 ml of 10% protease peptone (Difco). Monolayers were prepared as described (5) (Table 1) . Stimulation of the cells with concanavalin A did induce the production of lymphokine, however. Direct activation of macrophages to a cytolytic level was not found. By contrast, macrophages treated with supernatant culture medium and LPS (3 ng/ml) did kill. Therefore, the mitogen-induced lymphokine had a priming rather than a full activating effect. LPS was not required to obtain an antiviral effect and did not augment it. Also, the amounts of the two activities produced were dependent on cell concentration; a doubling of cell number from 1 x 106/ml to 2 x 106/ml increased each activity by the same amount, approximately 4-fold. tCytolytic units/ml, as determined by assay of macrophage-mediated 51Cr release from P815 mastocytoma cells (5) . tNIH reference units/ml of IFN activity, as measured in a plaque-reduction assay (11) modified for 6.4-mm-diameter flat-bottomed wells. § Fraction II (3 ng/ml) of phenol-extracted E. coli 0 1:B4 (10 (Fig. 1) . In fact, production levels of the two activities paralleled each other with a high degree of correlation (r = 0.949). In multiple experiments, subelone number 5 (24/G1.5) was consistently the best producer. The remainder of this work therefore was based on the activities produced by this subclone.
Sensitivity of Activities to Heat in Serum-Free Medium. Incubation at 56°C caused the concomitant loss of both activities ( Fig. 2; * Cytolytic units/ml measured in a 16-hr 5"Cr-release assay using P815 mastocytoma cells as targets (5) . tNIH reference units/ml of IFN activity, as measured in a plaque reduction assay (11) modified for 6.4-mm-diameter flat-bottomed wells.
Normal serum processed similarly to relevant antiserum.
Sephadex G-100 chromatography. Two separate batches of concentrated (50x) supernate were fractionated, each on a different column but bed volumes were similar. Activity in individual 3-ml fractions was quantified by both the antiviral and macrophage priming assays. In each of the two fractionations, single symmetrical peaks were obtained. In each case the elution profiles for the two activities were superimposed. The mean (+ SEM) estimated molecular weight from five separate assays was 51,117 ± 1,341 for macrophage priming activity and 51,402 ± 1,292 for the antiviral activity. Effect of Anti-IFN Antibodies. To this point we had been unable to separate the macrophage priming and antiviral activities in supernates of 24/G1.5 by any of the means tried. These results suggested that priming activity was being mediated by IFN-y. To test this hypothesis, experiments were performed with antibody made against either type I (mixture of IFN-a and IFN-3) or type II (IFN-y). Antibody against IFNy eliminated both the macrophage priming and antiviral effects of the 24/G1.5 supernate (Table 2) . By contrast, anti-IFN-a/ IFN-3 had little or no effect on either activity, although the antiviral activity of the mixture IFN-a/IFN-P was neutralized by this reagent completely and consistently. Repeated analyses showed that any slight inhibitory effects obtained when one kind (Table 2) ; the amount of this activity that was detectable in the IFN-a/IFN-, mixture was below the level that was quantifiable. Yet, the amounts of antiviral activity in the two IFN preparations were similar. These data suggested that the priming efficiencies of the two types of IFN might differ. This hypothesis was tested directly. As suspected, IFN-y was more efficient, per unit of antiviral activity, at priming macrophages than was the mixture (approximately 850 times) ( Table 4) .
DISCUSSION
We conclude from these data that IFN-y can prime murine macrophages for tumoricidal activity. This conclusion is based on the following criteria. (i) Correlation was always found between the amounts of antiviral and macrophage priming activities in the supernates of T-cell hybridoma subelones. (ii) The molecular weight associated with each activity was the same, as estimated by molecular sieve chromatography, and was within the range of molecular weights that has been reported for mouse . (iii) A highly specific polyclonal antibody made against mouse IFN-y neutralized both antiviral and macrophage priming activities, whereas an antibody made against a mixture of IFN-a and IFN-, had no effect. (iv) The ratio between the priming and antiviral activities in the hybridoma culture supernate was indistinguishable from that determined for recombinant mouse IFN-y. Recent reports by others showing that the priming and antiviral activities in culture supernates of mixed spleen cell populations are associated (15) , or even copurify (16), further support our conclusion.
Previous work has shown that type I IFN can activate macrophages to express cytotoxicity against tumor cells (17, 18 (19) (20) (21) (22) (23) (24) . Taken together these findings support the growing impression that the immunoregulatory functions of IFN-y may be more important than its antiviral function.
Finally, in light of the findings reported here, one is led to ask whether or not IFN and MAF are identical. Certainly, attention has previously been called to the striking functional and physicochemical similarities that exist between these two mediators (15, 25) , and the fact that they copurify (ref. 16 ; unpublished data). Furthermore, Kelso et 
